Related Experiment Videos
[Clinical study of subglottic carcinoma]
M Kashiwamura1, S Fukuda, S Maguchi
1Department of Otolaryngology, Hokkaido University School of Medicine, Sapporo.
Nihon Jibiinkoka Gakkai Kaiho
|February 1, 1995
Summary
Subglottic carcinoma has a poorer prognosis than other laryngeal cancers due to high recurrence rates after radiation and frequent metastasis. Surgery is recommended for most subglottic carcinoma cases, with adjuvant chemotherapy for advanced stages.
Area of Science:
- Otolaryngology
- Oncology
- Head and Neck Surgery
Context:
- Laryngeal carcinoma therapy is advancing, especially for early stages.
- Subtypes include supraglottic, glottic, and subglottic.
- Subglottic carcinoma historically shows a worse prognosis compared to other head and neck cancers.
Purpose:
- To analyze the diagnosis and treatment outcomes of subglottic carcinoma.
- To identify reasons for the poorer prognosis of subglottic carcinoma.
- To suggest optimized therapeutic strategies for subglottic carcinoma.
Summary:
- A study of 515 laryngeal carcinoma cases (1972-1990) found 27 (5.2%) were subglottic.
- Subglottic carcinoma exhibited a 5-year survival rate of 44%, significantly lower than other types.
- High local recurrence post-radiation and advanced-stage metastasis were key factors contributing to the poor survival rates.
Impact:
- Early-stage subglottic carcinoma (T1, T2) showed high local recurrence after radiotherapy, with salvage surgery yielding mixed results.
- Advanced-stage (T3, T4) subglottic carcinoma frequently metastasized, leading to fatal outcomes.
- Surgical intervention is proposed as the primary treatment for subglottic carcinoma (except T1), with adjuvant chemotherapy and neck dissection recommended for advanced cases.